查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946609

2026年全球下一代肿瘤治疗设备和解决方案市场报告

Next-Generation Oncology Devices And Solutions Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，新一代肿瘤治疗设备和解决方案市场规模迅速扩张，预计将从2025年的164.1亿美元成长到2026年的194.6亿美元，复合年增长率达18.6%。过去几年的成长可归因于全球癌症发生率的上升、分子诊断能力的增强、先进肿瘤检测工具的普及、医院癌症治疗计画的增加以及标靶治疗的日益普及。

预计未来几年，下一代肿瘤设备和解决方案市场将快速成长，到2030年市场规模将达到381.9亿美元，复合年增长率（CAGR）为18.4%。预测期内的成长要素包括：对个人化癌症治疗的需求不断增长、基因组诊断投资增加、早期筛检计画扩展、人工智慧在肿瘤工作流程中的应用日益广泛，以及基于生物标记的癌症管理技术不断进步。主要趋势包括：精准肿瘤平台的日益普及、基于次世代定序（NGS）的癌症诊断技术的广泛应用、数位病理解决方案的日益整合、个人化癌症治疗方法的扩展，以及对早期检测技术的日益重视。

癌症发生率的不断上升预计将推动下一代肿瘤治疗设备和解决方案市场的扩张。癌症是一种以异常细胞不受控制地生长为特征的疾病，这些异常细胞会扩散到身体其他部位并破坏正常功能。癌症发生率的上升主要是由于人口老化，罹患癌症风险老龄化增加而增加。下一代肿瘤治疗设备和解决方案透过实现早期检测、高精度诊断和个人化治疗，有助于应对这一日益增长的趋势。例如，根据美国非营利组织美国癌症协会于2024年1月发布的估计数据，美国癌症相关死亡人数将超过61.1万人，相当于每天超过1,600人死于癌症。因此，癌症发生率的不断上升是推动下一代肿瘤治疗设备和解决方案市场成长的主要因素。

下一代肿瘤设备和解决方案市场的主要企业正致力于技术创新，例如次世代定序(NGS)靶向序列捕获解决方案，以提高罕见基因突变检测的准确性、增强定序精度并加速癌症诊断和治疗决策。 NGS靶向序列捕获方案能够选择性地捕获和富集特定的 DNA 或 RNA 区域进行定序，从而实现对与癌症和其他疾病相关的基因突变进行更精确、更高效的分析。例如，2025 年 4 月，美国生物技术公司 Integrated DNA Technologies (IDT) 发布了 xGen Hybridization and Wash v3 Kit，这是一种先进的杂合反应捕获解决方案，可透过简化 NGS 工作流程来加速癌症研究。该试剂盒将杂合反应时间缩短至仅一小时，使研究人员能够在一天内完成从样本製备到定序的整个过程。此解决方案无需加热缓衝液，并将人工操作时间减少了 20%，非常适合自动化操作，是高通量应用的理想选择。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球下一代肿瘤治疗设备及解决方案市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 精准肿瘤学平台的广泛应用
    • 扩大基于次世代定序（NGS）的癌症诊断的应用
    • 数位病理解决方案的整合程度日益提高
    • 拓展个人化癌症治疗方法
    • 人们越来越关注早期检测技术

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 专业肿瘤中心
  • 学术研究机构
  • 癌症研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球下一代肿瘤治疗设备和解决方案市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球下一代肿瘤治疗设备及解决方案市场规模、对比及成长率分析
  • 全球下一代肿瘤治疗设备和解决方案市场表现：规模和成长，2020-2025年
  • 全球下一代肿瘤治疗设备及解决方案市场预测：规模及成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按癌症类型
  • 乳癌、子宫颈癌、结肠癌、肺癌
  • 透过技术
  • 次世代定序（NGS）、聚合酵素链锁反应（PCR）、DNA微阵列、多重分析及其他技术
  • 透过使用
  • 筛检和早期检测、预后诊断和后续观察、治疗选择、復发监测及其他用途
  • 按最终用途
  • 医院/诊所、诊断检查室、学术研究机构和其他最终用途
  • 按类型细分：乳癌
  • 侵袭性乳管癌、侵袭性小叶癌、三阴性乳癌、HER2阳性乳癌
  • 按类型细分：子宫颈癌
  • 鳞状细胞癌、腺癌、腺鳞癌
  • 按类型细分：大肠直肠癌
  • 结肠癌、直肠癌、转移性大肠癌
  • 按类型细分：肺癌
  • 非小细胞肺癌（NSCLC）、小细胞肺癌（SCLC）、肺腺癌、鳞状细胞肺癌

第十章 区域与国家分析

  • 全球下一代肿瘤治疗设备及解决方案市场：区域分析、预测及趋势（2020-2025年、2025-2030年预测、2035年预测）
  • 全球下一代肿瘤治疗设备及解决方案市场：国家/地区、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 下一代肿瘤治疗设备和解决方案市场：竞争格局和市场份额（2024 年）
  • 下一代肿瘤治疗设备及解决方案市场：公司估值矩阵
  • 下一代肿瘤治疗设备及解决方案市场：公司概况
    • Johnson & Johnson Services Inc.
    • Siemens AG
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Novartis AG

第37章：其他领先和创新企业

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN NV, Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年下一代肿瘤设备和解决方案市场：提供新机会的国家
  • 2030年下一代肿瘤设备和解决方案市场：提供新机会的细分市场
  • 2030年下一代肿瘤设备和解决方案市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MNGOD01_G26Q1

Next-generation oncology devices and solutions encompass advanced technologies and tools developed to detect, diagnose, monitor, and treat various forms of cancer with enhanced precision and speed. Their goal is to facilitate personalized cancer care by utilizing innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.

The primary cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a condition where cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or identified through imaging. These solutions employ technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced techniques, which are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and more.

Tariffs are influencing the next-generation oncology devices and solutions market by increasing costs of imported sequencing equipment, diagnostic reagents, imaging systems, electronic components, and precision manufacturing tools. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported advanced technologies, while Asia-Pacific faces pricing pressure on oncology device exports. These tariffs are raising testing and equipment costs and influencing procurement timelines. At the same time, they are encouraging domestic manufacturing, regional R&D investments, and local production of oncology diagnostic and therapeutic solutions.

The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including next-generation oncology devices and solutions industry global market size, regional shares, competitors with a next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $16.41 billion in 2025 to $19.46 billion in 2026 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of molecular diagnostic capabilities, availability of advanced oncology testing tools, growth of hospital-based cancer care programs, rising adoption of targeted therapies.

The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $38.19 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing demand for personalized cancer treatment, rising investments in genomic diagnostics, expansion of early screening programs, growing integration of ai in oncology workflows, advancements in biomarker-based cancer management. Major trends in the forecast period include increasing adoption of precision oncology platforms, rising use of ngs-based cancer diagnostics, growing integration of digital pathology solutions, expansion of personalized cancer treatment approaches, enhanced focus on early detection technologies.

The growing prevalence of cancer is expected to drive the expansion of the next-generation oncology devices and solutions market. Cancer is a disease characterized by uncontrolled growth of abnormal cells, which can spread to other areas of the body, disrupting normal functions. The increasing prevalence of cancer is mainly due to aging populations, as the risk of developing cancer rises with age. Next-generation oncology devices and solutions help address this rise by enabling earlier detection, more accurate diagnosis, and personalized treatment. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, estimated that cancer would cause over 611,000 deaths in the United States, which equals more than 1,600 cancer-related deaths per day. As such, the growing prevalence of cancer is a key driver for the growth of the next-generation oncology devices and solutions market.

Leading companies in the next-generation oncology devices and solutions market are focusing on technological innovations, such as next-generation sequencing (NGS) target enrichment solutions, to improve the detection of rare genetic variants, enhance sequencing accuracy, and expedite cancer diagnosis and treatment decisions. NGS target enrichment solutions involve techniques that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing more precise and efficient analysis of genetic variants associated with cancer and other diseases. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, an advanced hybridization capture solution designed to accelerate cancer research by streamlining NGS workflows. This kit reduces hybridization time to just one hour, enabling researchers to complete sample preparation and sequencing in a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and ideal for high-throughput applications.

In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. This acquisition aims to enhance Hologic's breast cancer surgery portfolio by incorporating Endomag's innovative surgical guidance products, which improve the precision and effectiveness of cancer care. Endomag, a UK-based medical device manufacturer, specializes in surgical guidance products for breast cancer treatment.

Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.

North America was the largest region in the next-generation oncology devices and solutions market in 2025. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Oncology Devices And Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation oncology devices and solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation oncology devices and solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation oncology devices and solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Cancer Type: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); DNA Microarrays; Multiplexing; Other Technologies
  • 3) By Application: Screening And Early Detection; Prognostics And Monitoring; Therapy Selection; Recurrence Monitoring; Other Applications
  • 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Uses
  • Subsegments:
  • 1) By Breast Cancer: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
  • 2) By Cervical Cancer: Squamous Cell Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
  • 3) By Colorectal Cancer: Colon Cancer; Rectal Cancer; Metastatic Colorectal Cancer
  • 4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Lung Adenocarcinoma; Squamous Cell Lung Carcinoma
  • Companies Mentioned: Johnson & Johnson Services Inc.; Siemens AG; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; QIAGEN N.V.; Exact Sciences Corporation; Elekta AB; Myriad Genetics Inc.; Takara Bio USA Inc.; NeoGenomics Inc.; Guardant Health Inc.; Accuray Incorporated; SOPHiA GENETICS SA; Paige.AI Inc.; Deep Bio Inc.; Lucida Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Next-Generation Oncology Devices And Solutions Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Next-Generation Oncology Devices And Solutions Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Next-Generation Oncology Devices And Solutions Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Next-Generation Oncology Devices And Solutions Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Precision Oncology Platforms
    • 4.2.2 Rising Use Of Ngs-Based Cancer Diagnostics
    • 4.2.3 Growing Integration Of Digital Pathology Solutions
    • 4.2.4 Expansion Of Personalized Cancer Treatment Approaches
    • 4.2.5 Enhanced Focus On Early Detection Technologies

5. Next-Generation Oncology Devices And Solutions Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Oncology Specialty Centers
  • 5.4 Academic And Research Institutions
  • 5.5 Cancer Research Organizations

6. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Oncology Devices And Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Next-Generation Oncology Devices And Solutions Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Oncology Devices And Solutions Market Segmentation

  • 9.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
  • 9.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
  • 9.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
  • 9.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
  • 9.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
  • 9.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
  • 9.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
  • 9.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

10. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis

  • 10.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Oncology Devices And Solutions Market

  • 11.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Oncology Devices And Solutions Market

  • 12.1. China Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Oncology Devices And Solutions Market

  • 13.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Oncology Devices And Solutions Market

  • 14.1. Japan Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Oncology Devices And Solutions Market

  • 15.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Oncology Devices And Solutions Market

  • 16.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Oncology Devices And Solutions Market

  • 17.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Oncology Devices And Solutions Market

  • 18.1. Taiwan Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Oncology Devices And Solutions Market

  • 19.1. South East Asia Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Oncology Devices And Solutions Market

  • 20.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Oncology Devices And Solutions Market

  • 21.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Oncology Devices And Solutions Market

  • 22.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Oncology Devices And Solutions Market

  • 23.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Oncology Devices And Solutions Market

  • 24.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Oncology Devices And Solutions Market

  • 25.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Oncology Devices And Solutions Market

  • 26.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Oncology Devices And Solutions Market

  • 27.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Oncology Devices And Solutions Market

  • 28.1. North America Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Oncology Devices And Solutions Market

  • 29.1. USA Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Oncology Devices And Solutions Market

  • 30.1. Canada Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Oncology Devices And Solutions Market

  • 31.1. South America Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Oncology Devices And Solutions Market

  • 32.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Oncology Devices And Solutions Market

  • 33.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Oncology Devices And Solutions Market

  • 34.1. Africa Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Oncology Devices And Solutions Market Regulatory and Investment Landscape

36. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles

  • 36.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Next-Generation Oncology Devices And Solutions Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Next-Generation Oncology Devices And Solutions Market Company Profiles
    • 36.3.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies

  • Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc.

38. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market

40. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies

  • 40.1 Next-Generation Oncology Devices And Solutions Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Next-Generation Oncology Devices And Solutions Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Next-Generation Oncology Devices And Solutions Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer